![Petra Kaufmann](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Petra Kaufmann
Directeur Technique/Scientifique/R&D chez VIGIL NEUROSCIENCE, INC.
Postes actifs de Petra Kaufmann
Sociétés | Poste | Début | Fin |
---|---|---|---|
VIGIL NEUROSCIENCE, INC. | Directeur Technique/Scientifique/R&D | 20/03/2024 | - |
Affinia Therapeutics, Inc.
![]() Affinia Therapeutics, Inc. BiotechnologyHealth Technology Affinia Therapeutics, Inc. is a preclinical stage company, which engages in the research and development of gene therapy. It offers Affinia Rationally-designed Therapies (ART) platform, which develops novel therapies, focusing on the key components of a gene therapy: capsids, which are the outer shells of a virus used to package the genetic code to treat a disease; promoters, which control how the cells read the genetic code that is delivered; and manufacturing approaches, which determine the quality and cost of potential medicines. The company was founded by Luk Vandenberghe, Botond Roska, and Aaron Tward in 2019 and is headquartered in Waltham, MA. | Directeur Technique/Scientifique/R&D | 01/02/2021 | - |
Historique de carrière de Petra Kaufmann
Anciens postes connus de Petra Kaufmann
Sociétés | Poste | Début | Fin |
---|---|---|---|
AVEXIS INC | Directeur Technique/Scientifique/R&D | 01/05/2020 | 01/02/2021 |
AVEXIS INC | Corporate Officer/Principal | 01/02/2018 | 01/05/2020 |
National Institutes of Health
![]() National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | 01/09/2015 | 01/02/2018 |
Formation de Petra Kaufmann
The Trustees of Columbia University in The City of New York | Graduate Degree |
University of Bonn | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 6 |
Allemagne | 2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 2 |
Graduate Degree | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 3 |
Government | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
VIGIL NEUROSCIENCE, INC. | Health Technology |
Entreprise privées | 3 |
---|---|
Affinia Therapeutics, Inc.
![]() Affinia Therapeutics, Inc. BiotechnologyHealth Technology Affinia Therapeutics, Inc. is a preclinical stage company, which engages in the research and development of gene therapy. It offers Affinia Rationally-designed Therapies (ART) platform, which develops novel therapies, focusing on the key components of a gene therapy: capsids, which are the outer shells of a virus used to package the genetic code to treat a disease; promoters, which control how the cells read the genetic code that is delivered; and manufacturing approaches, which determine the quality and cost of potential medicines. The company was founded by Luk Vandenberghe, Botond Roska, and Aaron Tward in 2019 and is headquartered in Waltham, MA. | Health Technology |
Novartis Gene Therapies, Inc.
![]() Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
National Institutes of Health
![]() National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Government |
- Bourse
- Insiders
- Petra Kaufmann
- Expérience